These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 34349242)
21. Loss of IDH2 Accelerates Age-related Hearing Loss in Male Mice. White K; Kim MJ; Han C; Park HJ; Ding D; Boyd K; Walker L; Linser P; Meneses Z; Slade C; Hirst J; Santostefano K; Terada N; Miyakawa T; Tanokura M; Salvi R; Someya S Sci Rep; 2018 Mar; 8(1):5039. PubMed ID: 29567975 [TBL] [Abstract][Full Text] [Related]
22. The heterocyclic compound Tempol inhibits the growth of cancer cells by interfering with glutamine metabolism. Ye S; Xu P; Huang M; Chen X; Zeng S; Wang Q; Chen J; Li K; Gao W; Liu R; Liu J; Shao Y; Zhang H; Xu Y; Zhang Q; Zhong Z; Wei Z; Wang J; Hao B; Huang W; Liu Q Cell Death Dis; 2020 May; 11(5):312. PubMed ID: 32366855 [TBL] [Abstract][Full Text] [Related]
23. Oxidative DNA damage is involved in ochratoxin A-induced G2 arrest through ataxia telangiectasia-mutated (ATM) pathways in human gastric epithelium GES-1 cells in vitro. Cui J; Liu J; Wu S; Wang Y; Shen H; Xing L; Wang J; Yan X; Zhang X Arch Toxicol; 2013 Oct; 87(10):1829-40. PubMed ID: 23515941 [TBL] [Abstract][Full Text] [Related]
24. 3'-hydroxy-4'-methoxy-β-methyl-β-nitrostyrene inhibits tumorigenesis in colorectal cancer cells through ROS-mediated DNA damage and mitochondrial dysfunction. Tsai CH; Hung AC; Chen YY; Chiu YW; Hsieh PW; Lee YC; Su YH; Chang PC; Hu SC; Yuan SF Oncotarget; 2017 Mar; 8(11):18106-18117. PubMed ID: 28178649 [TBL] [Abstract][Full Text] [Related]
25. SIRT5 promotes IDH2 desuccinylation and G6PD deglutarylation to enhance cellular antioxidant defense. Zhou L; Wang F; Sun R; Chen X; Zhang M; Xu Q; Wang Y; Wang S; Xiong Y; Guan KL; Yang P; Yu H; Ye D EMBO Rep; 2016 Jun; 17(6):811-22. PubMed ID: 27113762 [TBL] [Abstract][Full Text] [Related]
26. IDH2 deficiency impairs mitochondrial function in endothelial cells and endothelium-dependent vasomotor function. Park JB; Nagar H; Choi S; Jung SB; Kim HW; Kang SK; Lee JW; Lee JH; Park JW; Irani K; Jeon BH; Song HJ; Kim CS Free Radic Biol Med; 2016 May; 94():36-46. PubMed ID: 26898144 [TBL] [Abstract][Full Text] [Related]
27. Mitochondrial NADP Kong MJ; Han SJ; Kim JI; Park JW; Park KM Cell Death Dis; 2018 May; 9(5):488. PubMed ID: 29695796 [TBL] [Abstract][Full Text] [Related]
28. miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase. Zhou Y; Wan G; Spizzo R; Ivan C; Mathur R; Hu X; Ye X; Lu J; Fan F; Xia L; Calin GA; Ellis LM; Lu X Mol Oncol; 2014 Feb; 8(1):83-92. PubMed ID: 24145123 [TBL] [Abstract][Full Text] [Related]
29. SUMOylation enhances the activity of IDH2 under oxidative stress. Yu Y; Chen Y; Liu K; Cheng J; Tu J Biochem Biophys Res Commun; 2020 Nov; 532(4):591-597. PubMed ID: 32900482 [TBL] [Abstract][Full Text] [Related]
30. MicroRNA-18a attenuates DNA damage repair through suppressing the expression of ataxia telangiectasia mutated in colorectal cancer. Wu CW; Dong YJ; Liang QY; He XQ; Ng SS; Chan FK; Sung JJ; Yu J PLoS One; 2013; 8(2):e57036. PubMed ID: 23437304 [TBL] [Abstract][Full Text] [Related]
31. Emerging drug profile: Krebs cycle and cancer: IDH mutations and therapeutic implications. Lee S; Urman A; Desai P Leuk Lymphoma; 2019 Nov; 60(11):2635-2645. PubMed ID: 30958073 [TBL] [Abstract][Full Text] [Related]
32. The catalytic subunit of DNA-dependent protein kinase is required for cellular resistance to oxidative stress independent of DNA double-strand break repair. Li M; Lin YF; Palchik GA; Matsunaga S; Wang D; Chen BP Free Radic Biol Med; 2014 Nov; 76():278-85. PubMed ID: 25224041 [TBL] [Abstract][Full Text] [Related]
33. Increased susceptibility of IDH2-deficient mice to dextran sodium sulfate-induced colitis. Cha H; Lee S; Hwan Kim S; Kim H; Lee DS; Lee HS; Lee JH; Park JW Redox Biol; 2017 Oct; 13():32-38. PubMed ID: 28554049 [TBL] [Abstract][Full Text] [Related]
34. DNA double-strand breaks activate ATM independent of mitochondrial dysfunction in A549 cells. Kalifa L; Gewandter JS; Staversky RJ; Sia EA; Brookes PS; O'Reilly MA Free Radic Biol Med; 2014 Oct; 75():30-9. PubMed ID: 25048973 [TBL] [Abstract][Full Text] [Related]
35. Development of Novel Therapeutics Targeting Isocitrate Dehydrogenase Mutations in Cancer. Sharma H Curr Top Med Chem; 2018; 18(6):505-524. PubMed ID: 29773061 [TBL] [Abstract][Full Text] [Related]
36. Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability. Wise DR; Ward PS; Shay JE; Cross JR; Gruber JJ; Sachdeva UM; Platt JM; DeMatteo RG; Simon MC; Thompson CB Proc Natl Acad Sci U S A; 2011 Dec; 108(49):19611-6. PubMed ID: 22106302 [TBL] [Abstract][Full Text] [Related]
37. Telomeric DNA induces p53-dependent reactive oxygen species and protects against oxidative damage. Lee MS; Yaar M; Eller MS; Rünger TM; Gao Y; Gilchrest BA J Dermatol Sci; 2009 Dec; 56(3):154-62. PubMed ID: 19906512 [TBL] [Abstract][Full Text] [Related]
40. Mutant IDH1 Enhances Temozolomide Sensitivity via Regulation of the ATM/CHK2 Pathway in Glioma. Lin L; Cai J; Tan Z; Meng X; Li R; Li Y; Jiang C Cancer Res Treat; 2021 Apr; 53(2):367-377. PubMed ID: 33070553 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]